Eli Lilly & Co. (LLY): Price and Financial Metrics

LLY POWR Grades

• LLY scores best on the Quality dimension, with a Quality rank ahead of 90.59% of US stocks.
• The strongest trend for LLY is in Quality, which has been heading down over the past 163 days.
• LLY ranks lowest in Momentum; there it ranks in the 12th percentile.

LLY Stock Summary

• LLY has a market capitalization of $232,576,308,510 -- more than approximately 99.27% of US stocks.
• With a one year PEG ratio of 693.34, ELI LILLY & Co is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 96.1% of US stocks.
• ELI LILLY & Co's stock had its IPO on January 1, 1986, making it an older stock than 92.74% of US equities in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to ELI LILLY & Co are ABBV, NVO, TMO, ABT, and NFLX.
• LLY's SEC filings can be seen here. And to visit ELI LILLY & Co's official web site, go to www.lilly.com.

LLY Valuation Summary

• LLY's price/earnings ratio is 40.7; this is 11.51% higher than that of the median Healthcare stock.
• Over the past 243 months, LLY's price/earnings ratio has gone up 13.
• LLY's price/earnings ratio has moved up 13 over the prior 243 months.

Below are key valuation metrics over time for LLY.

LLY Growth Metrics

Its 5 year revenue growth rate is now at 14.41%.
• Its 3 year cash and equivalents growth rate is now at -11.75%.
• Its 5 year price growth rate is now at 103.4%.

LLY's revenue has moved up $5,287,400,000 over the prior 49 months.

The table below shows LLY's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-09-30	27,758.5	6,919.4	5,972.4
2021-06-30	26,726.3	7,094.7	6,070.7
2021-03-31	25,485.6	7,814.6	6,092.5
2020-12-31	24,539.8	6,499.6	6,193.7
2020-09-30	23,213.8	6,648.1	5,572.6
2020-06-30	22,949.8	6,351.6	5,618.1

LLY's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• LLY has a Quality Grade of B, ranking ahead of 90.11% of graded US stocks.
• LLY's asset turnover comes in at 0.586 -- ranking 60th of 681 Pharmaceutical Products stocks.
• BHC, VRTX, and DRRX are the stocks whose asset turnover ratios are most correlated with LLY.

The table below shows LLY's key quality metrics over time.